Literature DB >> 1329369

The DNA-binding protein P52 of human cytomegalovirus reacts with monoclonal antibody CCH2 and associates with the nuclear membrane at late times after infection.

B Plachter1, M Nordin, B Z Wirgart, M Mach, H Stein, L Grillner, G Jahn.   

Abstract

Monoclonal antibody CCH2 is commonly used for the detection of human cytomegalovirus (HCMV) infected cells in tissue sections as well as in cultured cells. The specificity of CCH2 was determined by screening a recombinant lambda-gt11 cDNA gene bank from HCMV-infected fibroblasts. By sequencing a reactive clone, the antigen was identified to be the non-structural DNA binding protein p52 of HCMV (UL44 reading frame). The viral insert from the lambda clone was recloned in bacterial expression vectors. For this, a new vector, pRos-RS, was constructed. The resulting clones were tested in immunoblot analyses. They were reactive with CCH2 as well as with reconvalescent sera positive for antibodies against HCMV, by this proving the specificity of CCH2. Using this monoclonal antibody in confocal microscopy, the subcellular localization of p52 in infected cells was analyzed. In these analyses, p52 was found to be nuclear and to be associated with the nuclear membrane at late times after infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329369     DOI: 10.1016/0168-1702(92)90123-q

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  The intracellular localization of human cytomegalovirus DNA in peripheral blood leukocytes during active infections by high-resolution fluorescence in situ hybridization.

Authors:  H Hackstein; H Kirchner; G Jahn; G Bein
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).

Authors:  J H Ahn; W J Jang; G S Hayward
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease.

Authors:  Rachele Ciccocioppo; Francesca Racca; Luigia Scudeller; Antonio Piralla; Pietro Formagnana; Lodovica Pozzi; Elena Betti; Alessandro Vanoli; Roberta Riboni; Peter Kruzliak; Fausto Baldanti; Gino Roberto Corazza
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

4.  Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining.

Authors:  C Sinzger; H Müntefering; T Löning; H Stöss; B Plachter; G Jahn
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90.

Authors:  Daisuke Kawashima; Teru Kanda; Takayuki Murata; Shinichi Saito; Atsuko Sugimoto; Yohei Narita; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

6.  In vivo Downregulation of MHC Class I Molecules by HCMV Occurs During All Phases of Viral Replication but Is Not Always Complete.

Authors:  Florin Gabor; Gerhard Jahn; Daniel D Sedmak; Christian Sinzger
Journal:  Front Cell Infect Microbiol       Date:  2020-06-12       Impact factor: 5.293

7.  Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells.

Authors:  Sven Seitz; Anna Theresa Heusel; Thomas Stamminger; Myriam Scherer
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.